SEC Comment Letter 0000000000-24-012721 to Plum Acquisition Corp, IV (PLMK, PLMKU, PLMKW) (CIK 0002030482) (PLMK)
Plum Acquisition Corp, IV (PLMK, PLMKU, PLMKW) (CIK 0002030482)
Date: Nov. 18, 2024 · CIK: 0002030482 · Accession: 0000000000-24-012721
AI Filing Summary & Sentiment
File numbers found in text: 333-281144
Letter
November 18, 2024 Kanishka Roy Chief Executive Officer Plum Acquisition Corp. IV 2021 Fillmore St. #2089 San Francisco, CA 94115 Re:Plum Acquisition Corp. IV Amendment No. 1 to Registration Statement on Form S-1 Filed November 5, 2024 File No. 333-281144 Dear Kanishka Roy: We have reviewed your amended registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our August 27, 2024 letter. Amendment No. 1 to Registration Statement on Form S-1 Cover Page 1.We note your disclosure regarding your restricted private placement shares. Please revise your cover page and Summary disclosures to clearly state, if true, that the non- managing investors will pay no additional consideration for these shares. Please further clarify, if true, that these shares could create a conflict of interest in that the non-managing investors will be incentivized to vote in favor of an initial business combination. Finally, please disclose, if true, that the restricted private placement shares will allow the non-managing investors to invest in your Company on more favorable terms than are available to purchasers in this offering.
November 18, 2024 Page 2 Summary Management Team, page 3 2.We note your response to comment 3 and re-issue in part. With respect to the redemptions of shares, please also quantify the percentage of outstanding shares that were redeemed. Select Leadership Council Members, page 6 3.Please provide the basis for the statement that Mike Dinsdale embodies the "modern unicorn" CFO. Please contact Sasha Parikh at 202-551-3627 or Lynn Dicker at 202-551-3616 if you have questions regarding comments on the financial statements and related matters. Please contact Jimmy McNamara at 202-551-7349 or Alan Campbell at 202-551-4224 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jason Simon
Show Raw Text
November 18, 2024
Kanishka Roy
Chief Executive Officer
Plum Acquisition Corp. IV
2021 Fillmore St. #2089
San Francisco, CA 94115
Re:Plum Acquisition Corp. IV
Amendment No. 1 to Registration Statement on Form S-1
Filed November 5, 2024
File No. 333-281144
Dear Kanishka Roy:
We have reviewed your amended registration statement and have the following
comments.
Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our August 27, 2024 letter.
Amendment No. 1 to Registration Statement on Form S-1
Cover Page
1.We note your disclosure regarding your restricted private placement shares. Please
revise your cover page and Summary disclosures to clearly state, if true, that the non-
managing investors will pay no additional consideration for these shares. Please
further clarify, if true, that these shares could create a conflict of interest in that the
non-managing investors will be incentivized to vote in favor of an initial business
combination. Finally, please disclose, if true, that the restricted private placement
shares will allow the non-managing investors to invest in your Company on more
favorable terms than are available to purchasers in this offering.
November 18, 2024
Page 2
Summary
Management Team, page 3
2.We note your response to comment 3 and re-issue in part. With respect to the
redemptions of shares, please also quantify the percentage of outstanding shares that
were redeemed.
Select Leadership Council Members, page 6
3.Please provide the basis for the statement that Mike Dinsdale embodies the "modern
unicorn" CFO.
Please contact Sasha Parikh at 202-551-3627 or Lynn Dicker at 202-551-3616 if you
have questions regarding comments on the financial statements and related matters. Please
contact Jimmy McNamara at 202-551-7349 or Alan Campbell at 202-551-4224 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jason Simon